Profile data is unavailable for this security.
About the company
KAKEN PHARMACEUTICAL CO., LTD. is a Japan-based company engaged in the production and sale of pharmaceutical products. The Company operates in two business segments. The Pharmaceutical segment involves in the manufacture and sale of pharmaceuticals, medical devices and agricultural drugs. The Real Estate segment is engaged in the leasing of real estate.
- Revenue in JPY (TTM)72.98bn
- Net income in JPY5.44bn
- Incorporated1948
- Employees1.16k
- LocationKaken Pharmaceutical Co Ltd20F, Bunkyo Green Court Center Office2-28-8, HonkomagomeBUNKYO-KU 113-8650JapanJPN
- Phone+81 359775001
- Fax+81 359775131
- Websitehttps://www.kaken.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Towa Pharmaceutical Co Ltd | 208.86bn | 2.20bn | 91.60bn | 4.08k | 40.33 | 0.6393 | 4.24 | 0.4386 | 44.09 | 44.09 | 4,219.21 | 2,781.16 | 0.5938 | 1.64 | 3.97 | -- | 0.6258 | 4.73 | 0.8634 | 6.39 | 34.81 | 41.27 | 1.05 | 8.06 | 1.15 | -- | 0.5413 | 19.74 | 26.11 | 17.46 | -86.17 | -19.46 | 14.66 | 13.63 |
| Shin Nippon Biomedical Laboratories Ltd | 25.09bn | 6.06bn | 94.42bn | 994.00 | 15.58 | 3.60 | 12.34 | 3.76 | 145.57 | 145.57 | 602.69 | 629.61 | 0.5197 | 2.06 | 6.12 | -- | 12.53 | 9.47 | 19.56 | 14.34 | 52.00 | 50.00 | 24.12 | 24.39 | 0.7886 | -- | 0.4158 | 19.11 | 41.37 | 8.61 | -14.98 | -- | 37.23 | -- |
| Torii Pharmaceutical Co Ltd | 49.75bn | 2.77bn | 101.23bn | 563.00 | 35.60 | 0.8437 | 31.30 | 2.03 | 98.73 | 98.73 | 1,770.51 | 4,166.29 | 0.3843 | 2.64 | 2.30 | 88,360,570.00 | 2.14 | 6.35 | 2.34 | 7.24 | 47.47 | 50.37 | 5.57 | 16.18 | 6.68 | -- | 0.00 | 20.83 | 4.06 | -5.28 | 16.89 | -3.52 | -18.66 | 15.81 |
| Kyorin Pharmaceutical Co Ltd | 113.27bn | 4.72bn | 111.58bn | 2.22k | 20.95 | 0.7888 | 13.03 | 0.9851 | 82.42 | 82.42 | 1,976.68 | 2,189.40 | 0.651 | 1.40 | 2.65 | -- | 2.72 | 3.20 | 3.36 | 3.93 | 44.29 | 48.72 | 4.17 | 5.10 | 2.03 | -- | 0.145 | 67.80 | 7.33 | 0.471 | 20.12 | -6.40 | 19.42 | -2.16 |
| ispace Inc | 989.24m | -11.40bn | 125.60bn | 220.00 | -- | -- | -- | 126.96 | -211.47 | -211.47 | 18.35 | -43.55 | -- | -- | -- | -- | -- | -- | -- | -- | 55.88 | -- | -1,152.22 | -- | 1.36 | -97.84 | 1.53 | -- | 46.74 | -- | -180.75 | -- | -- | -- |
| Mochida Pharmaceutical Co Ltd | 103.26bn | 6.65bn | 128.40bn | 1.54k | 18.76 | 0.961 | 13.78 | 1.24 | 177.78 | 177.78 | 2,778.76 | 3,470.18 | 0.6414 | 2.03 | 3.47 | -- | 4.13 | 4.86 | 5.02 | 5.94 | 53.37 | 52.20 | 6.44 | 7.36 | 3.41 | -- | -- | 41.67 | -6.28 | -0.6644 | -37.09 | -5.92 | 14.62 | -1.21 |
| Zeria Pharmaceutical Co Ltd | 68.38bn | 6.20bn | 130.30bn | 1.74k | 17.50 | 1.65 | 10.55 | 1.91 | 140.14 | 140.14 | 1,548.07 | 1,484.79 | 0.5274 | 1.53 | 4.14 | -- | 4.79 | 3.37 | 7.41 | 5.40 | 72.37 | 71.45 | 9.08 | 6.52 | 0.7515 | 6.27 | 0.4294 | 41.03 | 14.87 | 1.15 | 56.41 | 8.30 | 5.40 | 3.30 |
| Sawai Group Holdings Co Ltd | 200.34bn | 12.67bn | 145.30bn | 2.97k | 11.49 | 0.7206 | 4.76 | 0.7253 | 288.73 | 288.73 | 4,567.63 | 4,604.67 | 0.5615 | 1.47 | 3.03 | -- | 3.60 | 1.14 | 4.95 | 1.56 | 31.26 | 36.92 | 6.41 | 2.24 | 1.22 | 87.95 | 0.2558 | 80.41 | 3.37 | 3.58 | 144.81 | -2.01 | 10.06 | 0.00 |
| Kissei Pharmaceutical Co Ltd | 67.49bn | 10.53bn | 149.73bn | 1.83k | 12.66 | 0.6873 | 10.16 | 2.22 | 228.30 | 228.30 | 1,463.58 | 4,204.65 | 0.2939 | 1.68 | 2.96 | -- | 4.63 | 3.21 | 5.02 | 3.47 | 47.97 | 52.39 | 15.76 | 11.10 | 5.20 | -- | 0.0076 | 36.53 | 3.23 | -1.83 | -18.52 | 3.08 | 3.74 | 10.76 |
| KAKEN PHARMACEUTICAL CO., LTD. | 72.98bn | 5.44bn | 166.85bn | 1.16k | 25.16 | 0.9989 | 20.84 | 2.29 | 144.37 | 144.37 | 1,942.57 | 3,636.17 | 0.4403 | 2.19 | 3.69 | -- | 3.28 | 8.17 | 3.75 | 9.56 | 54.20 | 55.55 | 7.45 | 16.09 | 4.53 | -- | 0.0274 | 44.00 | -4.01 | -5.81 | -43.03 | -22.17 | 3.16 | 0.00 |
| JCR Pharmaceuticals Co Ltd | 34.34bn | 3.77bn | 178.77bn | 816.00 | 45.70 | 3.30 | 30.91 | 5.21 | 30.16 | 30.16 | 275.36 | 418.05 | 0.3576 | 0.5361 | 2.57 | -- | 3.94 | 9.63 | 6.66 | 14.67 | 74.13 | 74.34 | 11.03 | 19.32 | 0.819 | -- | 0.3031 | 26.30 | -32.77 | 10.77 | -74.00 | 4.20 | 53.67 | 25.21 |
| Takara Bio Inc | 78.14bn | 16.01bn | 201.82bn | 1.67k | 12.60 | 1.80 | 9.75 | 2.58 | 132.97 | 132.97 | 648.94 | 931.93 | 0.6381 | 1.90 | 5.29 | -- | 13.11 | 11.78 | 15.09 | 13.36 | 57.29 | 63.90 | 20.54 | 20.22 | 4.62 | 10,270.50 | 0.0086 | 24.14 | 15.43 | 19.32 | -19.33 | 46.97 | 29.87 | 56.32 |
| Tsumura & Co | 140.04bn | 16.48bn | 218.22bn | 3.92k | 13.19 | 0.8617 | 7.79 | 1.56 | 215.57 | 215.57 | 1,832.13 | 3,299.43 | 0.3746 | 0.738 | 2.49 | -- | 4.65 | 4.98 | 5.64 | 6.03 | 48.76 | 53.82 | 12.41 | 12.74 | 3.53 | -- | 0.2264 | 30.97 | 8.10 | 3.51 | -12.50 | 2.59 | 6.41 | 0.00 |
| Sosei Group Corp | 15.39bn | 1.05bn | 248.25bn | 202.00 | 272.07 | 4.24 | 103.01 | 16.13 | 11.08 | 11.08 | 185.73 | 710.59 | 0.1582 | -- | 11.86 | 76,202,970.00 | 1.08 | -- | 1.14 | -- | 95.26 | -- | 6.82 | -- | -- | 28.29 | 0.3392 | -- | -12.10 | -- | -62.44 | -- | -- | -- |
Data as of Jun 08 2023. Currency figures normalised to Kaken Pharmaceutical Co Ltd's reporting currency: Japanese Yen JPY
18.28%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Silchester International Investors LLPas of 25 Mar 2022 | 3.69m | 8.03% |
| Nomura Asset Management Co., Ltd.as of 28 Apr 2023 | 1.16m | 2.52% |
| The Vanguard Group, Inc.as of 05 May 2023 | 853.23k | 1.86% |
| Norges Bank Investment Managementas of 31 Dec 2022 | 521.47k | 1.14% |
| Daiwa Asset Management Co. Ltd.as of 31 Mar 2023 | 501.50k | 1.09% |
| Nikko Asset Management Co., Ltd.as of 02 May 2023 | 500.90k | 1.09% |
| BlackRock Fund Advisorsas of 04 May 2023 | 398.10k | 0.87% |
| Dimensional Fund Advisors LPas of 04 May 2023 | 307.94k | 0.67% |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd.as of 01 May 2023 | 271.60k | 0.59% |
| Brandes Investment Partners LPas of 01 Jun 2023 | 196.60k | 0.43% |
More ▼
Data from 31 Dec 2022 - 31 Mar 2023Source: FactSet Research Systems Inc.
